Potential Impact Investment Information:

Early Diagnostics

Should we invest in Early Diagnostics?

As part of our Colorectal Cancer Investment Cycle, CANCER FUND I, LLC is considering a potential investment in Early Diagnostics.

This page provides more details about Early Diagnostics for those interested in supporting Early Diagnostics through Cancer Fund I, LLC, including a summary of key points, a video of our July 19 CLOSER-LOOK session with co-founder and co-CEO Jasmine Zhou, Ph.D, and a presentation deck so you can learn more.

As a community of investors, CANCER FUND relies on the participation of members like you to fund these and other cancer innovations in our portfolio.


Potential Investment Status: Early Diagnostics

There are 6 steps in our investment process; Early Diagnostics is currently in Step 4. Advancing Early Diagnostics to Step 5 requires at least $35,000 in soft investment commitments from our community. With $12,325 already circled as of 8-9-23, an additional $22,675 in non-binding commitments are needed.

Will you join us in supporting Early Diagnostics through Cancer Fund I, LLC?

Join Us

If you’d like to join us in supporting cancer innovation by investing $100 or more into Cancer Fund I, LLC to support Early Diagnostics and other innovations, we are now accepting outside (non-founder) investors.

To submit your non-binding indication of interest,  CLICK HERE.

Needed to advance to Step 5


     – Commitments as of 8-10-23:


Committments Needed


Your Investment

$  ???   



Click below to view a recording of our CLOSER-LOOK Town Hall with EarlyDX co-founder and co-CEO Jasmine Zhou, Ph.D.



A One-Page Summary of EarlyDX


A Summary Overview on EarlyDX


A Look at the Science Behind EarlyDX